Anavex Life Sciences Corp. (AVXL) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Anavex Life Sciences Corp.
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system…
Source: Yahoo Finance
Sector & Industry
Anavex Life Sciences Corp. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Anavex Life Sciences Corp. at a Glance
| Company | Anavex Life Sciences Corp. |
| Ticker | AVXL |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $2.86 |
| Market cap | $265.11M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.14 |
| 52-week high | $10.40 |
| 52-week low | $2.25 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.14 |
| Return on equity (ROE) | -12.80% |
| Debt-to-equity | — |
| Average volume | 1.10M |
| Shares outstanding | 92.70M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 34 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Anavex Life Sciences Corp.'s current P/E ratio?
- Anavex Life Sciences Corp. (AVXL) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Anavex Life Sciences Corp.'s market capitalisation?
- Anavex Life Sciences Corp.'s market cap is $265.11M based on our latest snapshot. See how it ranks by market cap →
- What is AVXL's 52-week range?
- Over the past 52 weeks, AVXL has traded between $2.25 and $10.40. What does the 52-week range mean? →
- How volatile is Anavex Life Sciences Corp. compared to the market?
- Anavex Life Sciences Corp. has a beta of 1.14, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Anavex Life Sciences Corp. pay a dividend?
- Anavex Life Sciences Corp. does not currently pay a dividend according to our latest data.
- What exchange is AVXL listed on?
- AVXL is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Anavex Life Sciences Corp. in?
- Anavex Life Sciences Corp. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →